297 related articles for article (PubMed ID: 18173979)
1. Update on gout: pathophysiology and potential treatments.
Abeles AM; Park JY; Pillinger MH; Cronstein BN
Curr Pain Headache Rep; 2007 Dec; 11(6):440-6. PubMed ID: 18173979
[TBL] [Abstract][Full Text] [Related]
2. [Gout and cardiovascular risk].
Němec P
Vnitr Lek; 2014 Oct; 60(10):893-901. PubMed ID: 25382012
[TBL] [Abstract][Full Text] [Related]
3. [HYPERURICEMIA AND POTENTIAL RISK OF CARDIOVASCULAR AND RENAL DISEASES].
Schils R; Krzesinski JM
Rev Med Liege; 2016 May; 71(5):262-8. PubMed ID: 27337847
[TBL] [Abstract][Full Text] [Related]
4. Hyperuricemia and gout: new insights into pathogenesis and treatment.
Pillinger MH; Rosenthal P; Abeles AM
Bull NYU Hosp Jt Dis; 2007; 65(3):215-21. PubMed ID: 17922673
[TBL] [Abstract][Full Text] [Related]
5. Understanding treatments for gout.
Cannella AC; Mikuls TR
Am J Manag Care; 2005 Nov; 11(15 Suppl):S451-8; quiz S465-8. PubMed ID: 16300459
[TBL] [Abstract][Full Text] [Related]
6. The year in gout - 2010-2011.
Crittenden DB; Pillinger MH
Bull NYU Hosp Jt Dis; 2011; 69(3):257-63. PubMed ID: 22035440
[TBL] [Abstract][Full Text] [Related]
7. [Other antihyperuricemic agents].
Ogino K; Igawa O; Hisatome I
Nihon Rinsho; 2008 Apr; 66(4):754-7. PubMed ID: 18409527
[TBL] [Abstract][Full Text] [Related]
8. A review of uric acid, crystal deposition disease, and gout.
Perez-Ruiz F; Dalbeth N; Bardin T
Adv Ther; 2015 Jan; 32(1):31-41. PubMed ID: 25533440
[TBL] [Abstract][Full Text] [Related]
9. [Hyperuricemia, gout and high cardiovascular risk - how to manage them in clinical practice].
Fomin VV; Morosova TE; Tsurko VV
Ter Arkh; 2019 Dec; 91(12):75-83. PubMed ID: 32598593
[TBL] [Abstract][Full Text] [Related]
10. Why focus on uric acid?
Johnson RJ
Curr Med Res Opin; 2015; 31 Suppl 2():3-7. PubMed ID: 26414730
[TBL] [Abstract][Full Text] [Related]
11. Gout: a curable disease that often is undertreated. Long-term treatment is proven and available, but most patients and their physicians continue to take a short-term approach.
Duke Med Health News; 2014 Aug; 20(8):1-2. PubMed ID: 25230427
[No Abstract] [Full Text] [Related]
12. Update on gout 2012.
So A; Busso N
Joint Bone Spine; 2012 Dec; 79(6):539-43. PubMed ID: 23165182
[TBL] [Abstract][Full Text] [Related]
13. A magic bullet for gout?
So A; Busso N
Ann Rheum Dis; 2009 Oct; 68(10):1517-9. PubMed ID: 19748918
[No Abstract] [Full Text] [Related]
14. Investigational drugs for hyperuricemia, an update on recent developments.
Pascart T; Richette P
Expert Opin Investig Drugs; 2018 May; 27(5):437-444. PubMed ID: 29718730
[TBL] [Abstract][Full Text] [Related]
15. Hyperuricaemia and gout.
Shipley M
J R Coll Physicians Edinb; 2011 Sep; 41(3):229-33. PubMed ID: 21949921
[TBL] [Abstract][Full Text] [Related]
16. Update on gout and hyperuricemia.
Baker JF; Schumacher HR
Int J Clin Pract; 2010 Feb; 64(3):371-7. PubMed ID: 19909378
[TBL] [Abstract][Full Text] [Related]
17. [Physiopathology and treatment of gout and hyperuricemia].
Yamanaka H; Kamatani N
Nihon Naika Gakkai Zasshi; 1999 Apr; 88(4):718-23. PubMed ID: 10341662
[No Abstract] [Full Text] [Related]
18. Clinical practice. Gout.
Neogi T
N Engl J Med; 2011 Feb; 364(5):443-52. PubMed ID: 21288096
[No Abstract] [Full Text] [Related]
19. Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?
Ruoff G; Edwards NL
Postgrad Med; 2016 Sep; 128(7):706-15. PubMed ID: 27558643
[TBL] [Abstract][Full Text] [Related]
20. Gout in 2006: the perfect storm.
Terkeltaub R
Bull NYU Hosp Jt Dis; 2006; 64(1-2):82-6. PubMed ID: 17121496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
